Drug Type Small molecule drug |
Synonyms 3,3'-methylenebis(4-hydroxy-1,2-benzopyrone), 3,3'-methylenebis(4-hydroxy-2H-1-benzopyran-2-one), 3,3'-methylenebis(4-hydroxycoumarin) + [12] |
Target- |
Action antagonists |
Mechanism Vitamin K antagonists |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date United States (31 Jul 1944), |
Regulation- |
Molecular FormulaC19H12O6 |
InChIKeyDOBMPNYZJYQDGZ-UHFFFAOYSA-N |
CAS Registry66-76-2 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Venous Thrombosis | China | 01 Jan 1995 |